Aibotics Inc. (AIBT)
OTCMKTS
· Delayed Price · Currency is USD
0.0010
0.00 (2.04%)
Mar 9, 2026, 9:35 AM EST
Aibotics Market Cap
Aibotics has a market cap or net worth of $528.58 thousand as of March 9, 2026. Its market cap has increased by 260.12% in one year.
Market Cap
528.58K
Enterprise Value
1.78M
Revenue
2.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 21, 2021, Aibotics's market cap has decreased from 42.01M to 528.58K, a decrease of -98.74%. That is a compound annual growth rate of -57.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 528.58K | -56.58% |
| Dec 31, 2025 | 1.22M | 1,088.20% |
| Dec 30, 2024 | 102.44K | -57.02% |
| Dec 29, 2023 | 238.35K | -91.06% |
| Dec 30, 2022 | 2.67M | -91.49% |
| Dec 30, 2021 | 31.32M | -25.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovation Pharmaceuticals | 528.77K |
| Altamira Therapeutics | 542.97K |
| Hepion Pharmaceuticals | 488.05K |
| Windtree Therapeutics | 578.47K |
| Bio-Path Holdings | 593.40K |
| Scorpius Holdings | 672.57K |
| Oncology Pharma | 398.23K |
| SQZ Biotechnologies Company | 707.79K |